International Assets Investment Management LLC Raises Position in Teleflex Incorporated (NYSE:TFX)

International Assets Investment Management LLC grew its holdings in Teleflex Incorporated (NYSE:TFX) by 20,300.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,244 shares of the medical technology company’s stock after purchasing an additional 2,233 shares during the quarter. International Assets Investment Management LLC’s holdings in Teleflex were worth $560,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Rafferty Asset Management LLC lifted its stake in Teleflex by 6.8% in the 3rd quarter. Rafferty Asset Management LLC now owns 4,910 shares of the medical technology company’s stock worth $964,000 after purchasing an additional 314 shares in the last quarter. Royal London Asset Management Ltd. lifted its stake in Teleflex by 4.3% in the 3rd quarter. Royal London Asset Management Ltd. now owns 17,753 shares of the medical technology company’s stock worth $3,487,000 after purchasing an additional 737 shares in the last quarter. Raymond James & Associates lifted its stake in Teleflex by 10.5% in the 4th quarter. Raymond James & Associates now owns 126,227 shares of the medical technology company’s stock worth $31,473,000 after purchasing an additional 11,943 shares in the last quarter. Nordea Investment Management AB lifted its stake in Teleflex by 8.8% in the 4th quarter. Nordea Investment Management AB now owns 2,964 shares of the medical technology company’s stock worth $738,000 after purchasing an additional 239 shares in the last quarter. Finally, Venturi Wealth Management LLC purchased a new stake in shares of Teleflex during the 3rd quarter valued at approximately $27,000. 95.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. JMP Securities reaffirmed a “market outperform” rating and set a $285.00 price target on shares of Teleflex in a research report on Friday, February 23rd. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. Royal Bank of Canada reduced their price target on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. Finally, Truist Financial reduced their price target on shares of Teleflex from $270.00 to $265.00 and set a “hold” rating on the stock in a research report on Friday, February 23rd. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, Teleflex has an average rating of “Moderate Buy” and an average price target of $267.50.

Insiders Place Their Bets

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the business’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the completion of the transaction, the vice president now owns 10,050 shares in the company, valued at $2,261,250. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.43% of the company’s stock.

Teleflex Stock Performance

NYSE:TFX opened at $211.17 on Thursday. The company has a fifty day simple moving average of $223.09 and a two-hundred day simple moving average of $225.66. The company has a market cap of $9.95 billion, a price-to-earnings ratio of 28.04, a price-to-earnings-growth ratio of 1.98 and a beta of 1.11. The company has a quick ratio of 1.29, a current ratio of 2.32 and a debt-to-equity ratio of 0.39. Teleflex Incorporated has a 52 week low of $177.63 and a 52 week high of $276.43.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $3.38 EPS for the quarter, topping the consensus estimate of $3.26 by $0.12. The business had revenue of $773.90 million during the quarter, compared to the consensus estimate of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.52 earnings per share. As a group, equities analysts anticipate that Teleflex Incorporated will post 13.73 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were paid a $0.34 dividend. The ex-dividend date was Thursday, February 29th. This represents a $1.36 annualized dividend and a dividend yield of 0.64%. Teleflex’s dividend payout ratio (DPR) is 18.06%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.